The challenge
Alzheimer’s disease remains one of the most pressing medical challenges of our time. Traditional disease research methods rely heavily on infrequent clinical assessments, patient self-reporting, and small-scale studies, which often fail to capture the nuanced, day-to-day progression of the disease. Researchers lack continuous, objective insights into how Alzheimer’s affects cognitive function and biometrics in real-world conditions.
The solution
Margins developed the Lucidity app ecosystem for Alzheimer's disease research. Patients play 'brain games' on the app while biomedical devices collect real-time biometrics; an AI/ML model processes the biometric data against game outcomes, generating continuous, objective insights into disease progression — data that supports the ongoing search for an Alzheimer's cure.
Results
- AI healthtech ecosystem
- Dementia tracking
- Built with the Department of Neuroscience
- Output quality that exceeded expectations
They have helped us build a complex AI healthtech ecosystem for dementia tracking. Their responsiveness, independent problem-solving, and high-quality output exceeded our expectations.
Where could AI create the most value in your business?
Start with a conversation. We'll learn how your business operates, explore where AI could create meaningful value, and help determine which opportunities are worth pursuing.
Talk to our teamNo predetermined solution. No technology looking for a problem.